Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 27

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1A
Chunk 27
---
 maintain protection for our proprietary information could adversely affect our competitive business
position. 

46

Despite
our efforts to protect our proprietary rights, other parties may unintentionally or willfully disclose, obtain, or use our technologies
or systems, which may allow unauthorized parties to copy aspects of our platform or other software, technology, and functionality or
obtain and use information that we consider proprietary. In addition, unauthorized parties may also attempt, or successfully endeavor,
to obtain our intellectual property, confidential information, and trade secrets through various methods, including through scraping
of public data or other content from our website or mobile applications, cybersecurity attacks, and legal or other methods of protecting
this data may be inadequate. Monitoring unauthorized use and disclosures of our intellectual property, proprietary technology, or confidential
information can be difficult and expensive and we cannot be sure that the steps we have taken will prevent misappropriation or infringement
of our intellectual property or proprietary rights.

We
have registered the domain name for the website that we use in our business, which is www.conduitpharma.com. The inclusion of the website
address in this Annual Report does not include or incorporate by reference the information on the Company’s website into this document.

Competitors
have and may continue to adopt service names similar to ours, thereby harming our ability to build brand identity and possibly leading
to user confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other trademarks
that are similar to our trademarks. Further, litigation or proceedings before the U.S. Patent and Trademark Office or other governmental
authorities and administrative bodies in the U.S. and abroad may be necessary in the future to enforce our intellectual property rights
and to determine the validity and scope of the proprietary rights of others. Any litigation initiated by us concerning the violation
by third parties of our intellectual property rights is likely to be expensive and time-consuming and could lead to the invalidation
of, or render unenforceable, our intellectual property, or could otherwise have negative consequences for us. Even when we sue other
parties for such infringement, that suit may have adverse consequences for our business. In addition, we may not timely or successfully
apply for a patent or register our trademarks or otherwise secure our intellectual property, which could result in negative effects to
our market share, financial condition, and results of operations. Our efforts to protect, maintain, or enforce our proprietary rights
may not be respected in the future or may be invalidated, circumvented